3/4/2024 | BKIG | Moody’s revises Biogen outlook to stable
|
7/28/2023 | BKIG | Biogen expects to issue term debt for $7.3 billion acquisition of Reata
|
4/11/2022 | BKIG | Moody's downgrades Biogen
|
1/14/2022 | BKIG | Moody's eyes Biogen for downgrade
|
1/13/2022 | BKIG | S&P downgrades Biogen
|
11/10/2021 | BKIG | Moody's alters Biogen view to negative
|
2/16/2021 | IGLM | Biogen completes exchange, cash tender offers for 5.2% notes due 2045
|
2/11/2021 | IGLM | Biogen receives tenders for purchase, exchange of 5.2% notes due 2045
|
2/10/2021 | IGLM | Biogen prices exchange, cash tender offers for 5.2% notes due 2045
|
2/4/2021 | BKIG | Moody’s assign’s Biogen notes Baa1
|
2/4/2021 | IGLM | Biogen begins exchange, cash tender offers for 5.2% notes due 2045
|
11/9/2020 | BKIG | Moody’s eyes Biogen for downgrade
|
10/23/2020 | BKIG | S&P puts Biogen on watch
|
9/28/2020 | BKIG | Moody's revises Biogen view to negative
|
4/28/2020 | IG | New Issue: Biogen gives details on $3 billion issue of senior notes in two parts
|
4/27/2020 | IG | Market Commentary: Supply surges; Air Products, Biogen, Georgia-Pacific, Diageo, Emerson, BlackRock, IDEX price
|
4/27/2020 | IG | New Issue: Biogen prices $3 billion of senior notes in two tranches
|
4/27/2020 | BKIG | Moody's assigns Biogen notes Baa1
|
4/27/2020 | IG | Market Commentary: Morning Commentary: High-grade issuers flood primary; Biogen, Emerson, Diageo on deck
|
4/27/2020 | BKIG | S&P rates Biogen notes A-
|
4/27/2020 | IG | Biogen intends to conduct three-part sale of fixed-rate notes
|
4/24/2020 | IG | Market Commentary: Eli Lilly, Texas Instruments, Fairfax price; Biogen, Delta Air on tap; bank paper improves
|
4/24/2020 | IG | Biogen plans hefty bond offering following fixed income investor calls on Friday
|
5/3/2017 | BKIG | Moody’s lifts Biogen view to stable
|
10/21/2015 | BKBWIG | Biogen to cut workforce by 11%, operating expenses by $250 million
|
9/18/2015 | IG | Market Commentary: Morning Commentary: High-grade bonds mostly better; Biogen long bonds firm; Charter tightens
|
9/16/2015 | IG | Market Commentary: Morning Commentary: Disney notes firm in early secondary trading; Biogen tightens
|
9/15/2015 | IG | Market Commentary: American Campus upsizes; UDR, AEP Texas price notes; Disney tightens; credit spreads firm
|
9/15/2015 | IG | Market Commentary: Morning Commentary: St. Jude Medical improves in secondary market; Biogen notes remain tight
|
9/10/2015 | IG | Market Commentary: Biogen, Danaher price; American Airlines upsizes pass-throughs; HSBC, JPMorgan paper soft
|
9/10/2015 | IG | New Issue: Biogen prices $6 billion of senior notes in four maturities
|
9/10/2015 | BKIG | S&P rates Biogen notes A-
|
9/10/2015 | BKIG | Moody’s assigns Baa1 to Biogen notes
|
9/10/2015 | IG | Biogen talks benchmark senior notes in four tranches Thursday
|